Williams, A. and Louis, L. (2026) Cumulative Link Modeling of Ordinal Outcomes in the National Health Interview Survey Data: Application to Depressive Symptom Severity. Journal of Data Analysis and ...

Corporate leaders are racing to hire artificial intelligence talent, convinced that a few high-profile specialists can transform their businesses overnight. Instead, many are discovering that without ...

Overview: Healthcare data analysts turn patient and hospital data into useful insights.Strong demand exists as hospitals rely more on digital records.Skills in ...

Discover the best cloud ETL tools for data engineers in 2025. Compare features, pricing, and use cases as we explore the most effective data integration solutions for modern organizations with ...

The hottest big data tools in 2025 include Amazon Aurora DSQL, Snowflake Intelligence, and the Databricks Lakebase.

Tesla may be a global leader in electric vehicles, manufacturing, real world AI and renewable energy and therefore warrant a premium valuation, but for Morgan Stanley there’s a fair price for ...

Gold and silver futures fell Tuesday as traders took profits from recent highs amid some improvement in the risk appetite in the general marketplace. Silver fell after a run that spanned the previous ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...

Three data center stocks skyrocketed after releasing their latest financial results. However, Wall Street analysts appear concerned about two of these names, while being more optimistic about another.

Korro Bio (NASDAQ: KRRO) saw its stock reach its first of two all-time lows, cratering 81% Thursday after reporting disappointing data for its lead pipeline candidate KRRO-110, an RNA editing ...